Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder

Author： Yonkers Kimberly A Pearlstein Teri

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.7, 2002-07, pp. : 979-991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Premenstrual dysphoric disorder: is it simply PMS?

By Endicott J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 259-259

Elsevier

Access to resources Recommend Favorite

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen): A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris

By Fenton Caroline Wellington Keri Moen Marit D. Robinson Dean M.

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1749-1765

Adis International

Access to resources Recommend Favorite

Duloxetine for premenstrual dysphoric disorder: a pilot study

By Mazza Marianna Harnic Desiree Catalano Valeria Janiri Luigi Bria Pietro

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 517-521

Informa Healthcare

Access to resources Recommend Favorite

Luteal Phase Administration of Agents for the Treatment of Premenstrual Dysphoric Disorder

By Freeman E.W.

CNS Drugs, Vol. 18, Iss. 7, 2004-01 ,pp. : 453-468

Adis International

Access to resources Recommend Favorite

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline

By Halbreich Uriel Kahn Linda S

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2065-2078

Informa Healthcare

Access to resources Recommend Favorite